등온핵산증폭기술(INAAT) 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향, 예측(2024-2033년)

Isothermal Nucleic Acid Amplification Technology Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2033

US $ 4,995 ￦ 7,055,000

Unprintable PDF & Excel (Single User License)

PDF, Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 텍스트의 복사, 인쇄가 불가능합니다.

US $ 7,295 ￦ 10,304,000

PDF & Excel (Multi User License)

PDF, Excel 보고서를 동일 기업 내 5명까지 이용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste와 인쇄가 가능합니다.

US $ 8,495 ￦ 11,999,000

PDF & Excel (Corporate User License)

PDF, Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste와 인쇄가 가능합니다.

한글목차

Persistence Market Research는 등온핵산증폭기술(INAAT) 시장의 상세 분석을 발표하고, 복잡한 역학과 향후 궤도에 관한 인사이트를 제공하고 있습니다. 시장 동향부터 성장 촉매, 저해요인, 신규 패턴까지 2024-2033년의 귀중한 통계와 예측을 제공합니다.

주요 인사이트

• INAAT 시장 규모(2024년) : 52억 6,000만 달러
• 시장 예측치(2033년) : 145억 6,000만 달러
• 세계 시장 성장률(CAGR 2024-2033년) : 12.0%

INAAT 시장 - 리포트 범위 :

INAAT 시장은 헬스케어, 제약, 바이오테크놀러지 등 산업 전반에 걸쳐 다양한 용도를 포괄하고 있으며, INAAT는 질병 진단, 병원체 검출, 유전자 검사에 필수적인 핵산의 신속하고 정확한 검출에 널리 사용되고 있습니다. 이 시장은 병원, 진단 실험실, 연구기관, 바이오 제약사 등 다양한 최종사용자를 대상으로 하며, 임상 및 연구용으로 활용도가 높은 다용도한 기술을 제공합니다. 시장 성장의 원동력은 기술 발전, 현장 진단에 대한 수요 증가, 감염성 질환의 유행과 같은 요인에 기인합니다.

시장 성장 촉진요인 :

세계 INAAT 시장은 몇 가지 주요 성장 촉진요인에 의해 지원되고 있습니다. 분자진단의 기술 발전은 INAAT의 효율성과 적용을 향상시키고 다양한 산업에서 채택을 촉진할 것입니다. 또한 특히 신흥 국가에서의 현장 진단에 대한 수요 증가는 신속하고 정확한 질병 검출을 위한 핵심 기술로서 INAAT에 대한 큰 수요를 창출하고 있습니다. 또한 감염성 질환의 조기 및 정확한 진단에 대한 중요성이 강조되면서 새로운 INAAT 플랫폼 및 분석법 개발이 활발히 이루어지고 있습니다.

시장 성장 억제요인:

INAAT 시장은 유망한 성장 전망에도 불구하고 규제 준수, 대체 기술과의 경쟁, 높은 비용 등의 문제에 직면해 있습니다. 진단 기술에 대한 엄격한 규제 요건은 제조업체와 최종사용자에게 규정 준수에 대한 부담을 가중시켜 시장 확대에 영향을 미치고 있습니다. 또한 PCR과 같은 다른 핵산 증폭 기술과의 경쟁으로 인해 INAAT의 보급에 어려움을 겪고 있습니다. 또한 INAAT 플랫폼 및 시약과 관련된 높은 비용은 시장 성장에 영향을 미칠 수 있으며, 비용 효율적인 솔루션 개발이 필요합니다.

시장 기회 :

INAAT 시장은 기술 혁신, 업계 제휴, 시장 다변화를 통해 유리한 성장 기회를 제공합니다. 맞춤형 의료, 전염병 유행, 유전자 연구의 발전과 같은 새로운 트렌드는 제조업체들이 임상 및 연구 분야에서 INAAT의 새로운 용도와 제형을 모색하는 계기가 되고 있습니다. 또한 전략적 파트너십, 공동연구, 인수합병(M&A)을 통해 시장 진출기업은 제품 포트폴리오를 확장하고, 기술력을 강화하며, 주요 지역에서 시장 입지를 강화하고 있습니다. 또한 연구개발에 대한 투자 증가와 혁신 및 헬스케어 인프라에 대한 정부의 지원 증가는 시장 확대와 다각화를 촉진하는 환경을 조성하고 있습니다.

이 보고서에서 다룬 주요 질문

• INAAT 시장의 세계 성장을 가속하는 주요 요인은 무엇인가?
• 기술 발전과 업계 동향은 INAAT의 응용과 제형 진화를 어떻게 형성하고 있는가?
• INAAT 분야 시장 진출기업이 직면한 주요 도전과 기회는 무엇인가?
• INAAT 제조업체가 가장 성장할 가능성이 높은 산업 분야와 지역은?
• INAAT 제품을 차별화하고 경쟁 구도에서 시장 점유율을 확보하기 위해 주요 기업은 어떤 전략을 채택하고 있는가?

목차

제1장 주요 요약

제2장 시장 개요

• 시장 범위/분류
• 시장의 정의/범위/제한

제3장 시장 배경

• 시장 역학
• 시나리오 예측
• 기회 맵 분석
• 투자 실현 가능성 매트릭스
• PESTLE과 Porter의 산업 분석
• 규제 상황
• 지역 모시장 전망

제4장 세계의 등온핵산증폭기술(INAAT) 시장 분석

• 과거 시장 규모 가치(금액) 분석, 2019-2023년
• 현재 및 향후 시장 규모 가치(금액) 예측, 2024-2033년
  • 전년대비 성장 동향 분석
  • 절대적 매출 기회 분석

제5장 세계의 등온핵산증폭기술(INAAT) 시장 분석 : 제품별

• 서론/주요 조사 결과
• 과거 시장 규모(금액) 분석, 2019-2023년
• 현재 및 향후 시장 규모(금액) 분석과 예측, 2024-2033년
  • 기기
  • 시약
• 전년대비 성장 동향 분석, 2019-2023년
• 절대적 매출 기회 분석, 2024-2033년

제6장 세계의 등온핵산증폭기술(INAAT) 시장 분석 : 기술별

• 서론/주요 조사 결과
• 과거 시장 규모(금액) 분석, 2019-2023년
• 현재 및 향후 시장 규모(금액) 분석과 예측, 2024-2033년
  • NASBA
  • HAD
  • LAMP
  • SDA
  • SPIA
  • NEAR
  • TMA
  • RCA
  • RPA
  • SMAP2
  • 기타
• 전년대비 성장 동향 분석, 2019-2023년
• 절대적 매출 기회 분석, 2024-2033년

제7장 세계의 등온핵산증폭기술(INAAT) 시장 분석 : 용도별

• 서론/주요 조사 결과
• 과거 시장 규모(금액) 분석, 2019-2023년
• 현재 및 향후 시장 규모(금액) 분석과 예측, 2024-2033년
  • 혈액검사
  • 감염증 진단
  • 암
  • 기타
• 전년대비 성장 동향 분석, 2019-2023년
• 절대적 매출 기회 분석, 2024-2033년

제8장 세계의 등온핵산증폭기술(INAAT) 시장 분석 : 최종 용도별

• 서론/주요 조사 결과
• 과거 시장 규모(금액) 분석, 2019-2023년
• 현재 및 향후 시장 규모(금액) 분석과 예측, 2024-2033년
  • 병원
  • 센트럴 랩 및 표준실험실
  • 기타
• 전년대비 성장 동향 분석, 2019-2023년
• 절대적 매출 기회 분석, 2024-2033년

제9장 지역별 세계 등온핵산증폭기술(INAAT) 시장 분석

• 서론
• 과거 시장 규모(금액) 분석, 2019-2023년
• 현재 시장 규모(금액) 분석과 예측, 2024-2033년
  • 북미
  • 라틴아메리카
  • 유럽
  • 아시아태평양
  • 중동 및 아프리카
• 지역별 시장의 매력 분석

제10장 북미의 등온핵산증폭기술(INAAT) 시장 분석(국가별)

제11장 라틴아메리카의 등온핵산증폭기술(INAAT) 시장 분석(국가별)

제12장 유럽의 등온핵산증폭기술(INAAT) 시장 분석(국가별)

제13장 아시아태평양의 등온핵산증폭기술(INAAT) 시장 분석(국가별)

제14장 국가별 중동 및 아프리카의 등온핵산증폭기술(INAAT) 시장 분석

제15장 주요 국가에서 등온핵산증폭기술(INAAT) 시장 분석

• 미국
• 캐나다
• 브라질
• 멕시코
• 독일
• 영국
• 프랑스
• 스페인
• 이탈리아
• 중국
• 일본
• 한국
• 말레이시아
• 싱가포르
• 호주
• 뉴질랜드
• GCC 국가
• 남아프리카공화국
• 이스라엘

제16장 시장 구조 분석

• 경쟁 대시보드
• 경쟁 벤치마킹
• 주요 기업의 시장 점유율 분석

제17장 경쟁 분석

• 경쟁의 상세
  • Alere, Inc.
  • bioMerieux SA
  • Eiken Chemical Co. Ltd
  • Hologic Inc.(Gen-Probe)
  • Lucigen
  • Meridian Bioscience, Inc.
  • Ustar Biotechnologies Ltd.
  • QIAGEN
  • Quidel Corporation
  • Thermo Fisher Scientific, Inc.
  • BD(Becton, Dickinson &Company)

제18장 사용되는 전제 조건과 두자어

제19장 조사 방법

KSA

영문 목차

영문목차

Persistence Market Research presents an in-depth analysis of the Isothermal Nucleic Acid Amplification Technology (INAAT) Market, offering insights into its intricate dynamics and future trajectory. From market trends to growth catalysts, impediments, and emerging patterns, this report furnishes invaluable statistics and projections spanning from 2024 to 2033.

Key Insights:

• INAAT Market Size (2024): USD 5.26 Billion
• Projected Market Value (2033): USD 14.56 Billion
• Global Market Growth Rate (CAGR 2024 to 2033): 12.0%

INAAT Market - Report Scope:

The INAAT Market encompasses various applications across industries such as healthcare, pharmaceuticals, and biotechnology. INAAT is widely used for the rapid and accurate detection of nucleic acids, making it essential in disease diagnostics, pathogen detection, and genetic testing. This market caters to a wide range of end-users, including hospitals, diagnostic laboratories, research institutes, and biopharmaceutical companies, offering a versatile technology with numerous clinical and research applications. Market growth is driven by factors such as technological advancements, increasing demand for point-of-care diagnostics, and the rising prevalence of infectious diseases.

Market Growth Drivers:

The global INAAT Market is bolstered by several key growth drivers. Technological advancements in molecular diagnostics enhance the efficiency and applications of INAAT, driving its adoption across various industries. Moreover, the increasing demand for point-of-care diagnostics, especially in emerging economies, creates significant demand for INAAT as a key technology for rapid and accurate disease detection. Additionally, the growing emphasis on early and precise diagnosis of infectious diseases stimulates research and development activities, leading to the development of novel INAAT platforms and assays.

Market Restraints:

Despite its promising growth prospects, the INAAT Market faces challenges related to regulatory compliance, competition from alternative technologies, and high costs. Stringent regulatory requirements regarding diagnostic technologies impose compliance burdens on manufacturers and end-users, impacting market expansion. Furthermore, competition from other nucleic acid amplification technologies, such as PCR, poses challenges to the widespread adoption of INAAT. Additionally, the high costs associated with INAAT platforms and reagents can affect market growth, necessitating the development of cost-effective solutions.

Market Opportunities:

The INAAT Market presents lucrative growth opportunities driven by technological innovation, industry collaborations, and market diversification. Emerging trends such as personalized medicine, infectious disease outbreaks, and advancements in genetic research inspire manufacturers to explore new applications and formulations for INAAT in clinical and research settings. Moreover, strategic partnerships, research collaborations, and mergers and acquisitions enable market players to expand their product portfolios, enhance their technical capabilities, and strengthen their market presence in key regions. Furthermore, growing investments in research and development, coupled with increasing government support for innovation and healthcare infrastructure, create a conducive environment for market expansion and diversification.

Key Questions Answered in the Report:

• What are the primary factors driving the growth of the INAAT Market globally?
• How are technological advancements and industry trends shaping the evolution of INAAT applications and formulations?
• What are the key challenges and opportunities facing market participants in the INAAT segment?
• Which industrial sectors and geographic regions offer the highest growth potential for INAAT manufacturers?
• What strategies are leading companies employing to differentiate their INAAT offerings and capture market share in the competitive diagnostic landscape?

Competitive Intelligence and Business Strategy:

Leading players in the global INAAT Market, including diagnostic companies, pharmaceutical firms, and biotechnology enterprises, focus on innovation, product differentiation, and market expansion to gain a competitive edge. These companies invest in research and development to develop advanced INAAT technologies, improve product quality, and explore new applications for INAAT in various industries. Moreover, strategic collaborations with research institutions, academic partners, and industry associations enable market players to access new technologies, expand their knowledge base, and accelerate product development efforts. Furthermore, emphasis on regulatory compliance, quality assurance, and customer support enhances brand reputation and fosters long-term relationships with customers and stakeholders.

Key Companies Profiled:

• Alere, Inc.
• bioMerieux SA
• Eiken Chemical Co. Ltd
• Hologic Inc.(Gen-Probe)
• Lucigen
• Meridian Bioscience, Inc.
• Ustar Biotechnologies Ltd.
• QIAGEN
• Quidel Corporation
• Thermo Fisher Scientific, Inc.
• BD (Becton, Dickinson & Company)
• OptiGene Limited

INAAT Market Research Segmentation:

By Product Type

• Instruments
• Reagent

By Technology

• NASBA
• HDA
• LAMP
• SDA
• SPIA
• NEAR
• TMA
• RCA
• RPA
• SMAP2
• Others

By Application

• Blood Screening
• Infectious Disease Diagnostics
• Cancer
• Others

By End User

• Hospitals
• Central & Reference Labs
• Others

By Region

• North America Market
• Europe Market
• Asia Pacific Market
• Middle East & Africa Market
• South America Market

Table of Contents

1. Executive Summary

• 1.1. Global Market Outlook
• 1.2. Demand-side Trends
• 1.3. Supply-side Trends
• 1.4. Technology Roadmap Analysis
• 1.5. Analysis and Recommendations

2. Market Overview

• 2.1. Market Coverage / Taxonomy
• 2.2. Market Definition / Scope / Limitations

3. Market Background

• 3.1. Market Dynamics
  • 3.1.1. Drivers
  • 3.1.2. Restraints
  • 3.1.3. Opportunity
  • 3.1.4. Trends
• 3.2. Scenario Forecast
  • 3.2.1. Demand in Optimistic Scenario
  • 3.2.2. Demand in Likely Scenario
  • 3.2.3. Demand in Conservative Scenario
• 3.3. Opportunity Map Analysis
• 3.4. Investment Feasibility Matrix
• 3.5. PESTLE and Porter's Analysis
• 3.6. Regulatory Landscape
  • 3.6.1. By Key Regions
  • 3.6.2. By Key Countries
• 3.7. Regional Parent Market Outlook

4. Global Isothermal Nucleic Acid Amplification Technology Market Analysis 2019-2023 and Forecast, 2024-2033

• 4.1. Historical Market Size Value (US$ Bn) Analysis, 2019-2023
• 4.2. Current and Future Market Size Value (US$ Bn) Projections, 2024-2033
  • 4.2.1. Y-o-Y Growth Trend Analysis
  • 4.2.2. Absolute $ Opportunity Analysis

5. Global Isothermal Nucleic Acid Amplification Technology Market Analysis 2019-2023 and Forecast 2024-2033, By Product

• 5.1. Introduction / Key Findings
• 5.2. Historical Market Size Value (US$ Bn) Analysis By Product , 2019-2023
• 5.3. Current and Future Market Size Value (US$ Bn) Analysis and Forecast By Product , 2024-2033
  • 5.3.1. Instruments
  • 5.3.2. Reagent
• 5.4. Y-o-Y Growth Trend Analysis By Product , 2019-2023
• 5.5. Absolute $ Opportunity Analysis By Product , 2024-2033

6. Global Isothermal Nucleic Acid Amplification Technology Market Analysis 2019-2023 and Forecast 2024-2033, By Technology

• 6.1. Introduction / Key Findings
• 6.2. Historical Market Size Value (US$ Bn) Analysis By Technology, 2019-2023
• 6.3. Current and Future Market Size Value (US$ Bn) Analysis and Forecast By Technology, 2024-2033
  • 6.3.1. NASBA
  • 6.3.2. HAD
  • 6.3.3. LAMP
  • 6.3.4. SDA
  • 6.3.5. SPIA
  • 6.3.6. NEAR
  • 6.3.7. TMA
  • 6.3.8. RCA
  • 6.3.9. RPA
  • 6.3.10. SMAP2
  • 6.3.11. Others
• 6.4. Y-o-Y Growth Trend Analysis By Technology, 2019-2023
• 6.5. Absolute $ Opportunity Analysis By Technology, 2024-2033

7. Global Isothermal Nucleic Acid Amplification Technology Market Analysis 2019-2023 and Forecast 2024-2033, By Application

• 7.1. Introduction / Key Findings
• 7.2. Historical Market Size Value (US$ Bn) Analysis By Application , 2019-2023
• 7.3. Current and Future Market Size Value (US$ Bn) Analysis and Forecast By Application , 2024-2033
  • 7.3.1. Blood Screening
  • 7.3.2. Infectious Disease Diagnostics
  • 7.3.3. Cancer
  • 7.3.4. Others
• 7.4. Y-o-Y Growth Trend Analysis By Application , 2019-2023
• 7.5. Absolute $ Opportunity Analysis By Application , 2024-2033

8. Global Isothermal Nucleic Acid Amplification Technology Market Analysis 2019-2023 and Forecast 2024-2033, By End-use

• 8.1. Introduction / Key Findings
• 8.2. Historical Market Size Value (US$ Bn) Analysis By End-use, 2019-2023
• 8.3. Current and Future Market Size Value (US$ Bn) Analysis and Forecast By End-use, 2024-2033
  • 8.3.1. Hospitals
  • 8.3.2. Central & Reference Labs
  • 8.3.3. Others
• 8.4. Y-o-Y Growth Trend Analysis By End-use, 2019-2023
• 8.5. Absolute $ Opportunity Analysis By End-use, 2024-2033

9. Global Isothermal Nucleic Acid Amplification Technology Market Analysis 2019-2023 and Forecast 2024-2033, By Region

• 9.1. Introduction
• 9.2. Historical Market Size Value (US$ Bn) Analysis By Region, 2019-2023
• 9.3. Current Market Size Value (US$ Bn) Analysis and Forecast By Region, 2024-2033
  • 9.3.1. North America
  • 9.3.2. Latin America
  • 9.3.3. Europe
  • 9.3.4. Asia Pacific
  • 9.3.5. MEA
• 9.4. Market Attractiveness Analysis By Region

10. North America Isothermal Nucleic Acid Amplification Technology Market Analysis 2019-2023 and Forecast 2024-2033, By Country

• 10.1. Historical Market Size Value (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
• 10.2. Market Size Value (US$ Bn) Forecast By Market Taxonomy, 2024-2033
  • 10.2.1. By Country
    • 10.2.1.1. U.S.
    • 10.2.1.2. Canada
  • 10.2.2. By Product
  • 10.2.3. By Technology
  • 10.2.4. By Application
  • 10.2.5. By End-use
• 10.3. Market Attractiveness Analysis
  • 10.3.1. By Country
  • 10.3.2. By Product
  • 10.3.3. By Technology
  • 10.3.4. By Application
  • 10.3.5. By End-use
• 10.4. Key Takeaways

11. Latin America Isothermal Nucleic Acid Amplification Technology Market Analysis 2019-2023 and Forecast 2024-2033, By Country

• 11.1. Historical Market Size Value (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
• 11.2. Market Size Value (US$ Bn) Forecast By Market Taxonomy, 2024-2033
  • 11.2.1. By Country
    • 11.2.1.1. Brazil
    • 11.2.1.2. Mexico
    • 11.2.1.3. Rest of Latin America
  • 11.2.2. By Product
  • 11.2.3. By Technology
  • 11.2.4. By Application
  • 11.2.5. By End-use
• 11.3. Market Attractiveness Analysis
  • 11.3.1. By Country
  • 11.3.2. By Product
  • 11.3.3. By Technology
  • 11.3.4. By Application
  • 11.3.5. By End-use
• 11.4. Key Takeaways

12. Europe Isothermal Nucleic Acid Amplification Technology Market Analysis 2019-2023 and Forecast 2024-2033, By Country

• 12.1. Historical Market Size Value (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
• 12.2. Market Size Value (US$ Bn) Forecast By Market Taxonomy, 2024-2033
  • 12.2.1. By Country
    • 12.2.1.1. Germany
    • 12.2.1.2. U.K.
    • 12.2.1.3. France
    • 12.2.1.4. Spain
    • 12.2.1.5. Italy
    • 12.2.1.6. Rest of Europe
  • 12.2.2. By Product
  • 12.2.3. By Technology
  • 12.2.4. By Application
  • 12.2.5. By End-use
• 12.3. Market Attractiveness Analysis
  • 12.3.1. By Country
  • 12.3.2. By Product
  • 12.3.3. By Technology
  • 12.3.4. By Application
  • 12.3.5. By End-use
• 12.4. Key Takeaways

13. Asia Pacific Isothermal Nucleic Acid Amplification Technology Market Analysis 2019-2023 and Forecast 2024-2033, By Country

• 13.1. Historical Market Size Value (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
• 13.2. Market Size Value (US$ Bn) Forecast By Market Taxonomy, 2024-2033
  • 13.2.1. By Country
    • 13.2.1.1. China
    • 13.2.1.2. Japan
    • 13.2.1.3. South Korea
    • 13.2.1.4. India
    • 13.2.1.5. Malaysia
    • 13.2.1.6. Singapore
    • 13.2.1.7. Australia
    • 13.2.1.8. New Zealand
    • 13.2.1.9. Rest of APAC
  • 13.2.2. By Product
  • 13.2.3. By Technology
  • 13.2.4. By Application
  • 13.2.5. By End-use
• 13.3. Market Attractiveness Analysis
  • 13.3.1. By Country
  • 13.3.2. By Product
  • 13.3.3. By Technology
  • 13.3.4. By Application
  • 13.3.5. By End-use
• 13.4. Key Takeaways

14. MEA Isothermal Nucleic Acid Amplification Technology Market Analysis 2019-2023 and Forecast 2024-2033, By Country

• 14.1. Historical Market Size Value (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
• 14.2. Market Size Value (US$ Bn) Forecast By Market Taxonomy, 2024-2033
  • 14.2.1. By Country
    • 14.2.1.1. GCC Countries
    • 14.2.1.2. South Africa
    • 14.2.1.3. Israel
    • 14.2.1.4. Rest of MEA
  • 14.2.2. By Product
  • 14.2.3. By Technology
  • 14.2.4. By Application
  • 14.2.5. By End-use
• 14.3. Market Attractiveness Analysis
  • 14.3.1. By Country
  • 14.3.2. By Product
  • 14.3.3. By Technology
  • 14.3.4. By Application
  • 14.3.5. By End-use
• 14.4. Key Takeaways

15. Key Countries Isothermal Nucleic Acid Amplification Technology Market Analysis

• 15.1. U.S.
  • 15.1.1. Pricing Analysis
  • 15.1.2. Market Share Analysis, 2024
    • 15.1.2.1. By Product
    • 15.1.2.2. By Technology
    • 15.1.2.3. By Application
    • 15.1.2.4. By End-use
• 15.2. Canada
  • 15.2.1. Pricing Analysis
  • 15.2.2. Market Share Analysis, 2024
    • 15.2.2.1. By Product
    • 15.2.2.2. By Technology
    • 15.2.2.3. By Application
    • 15.2.2.4. By End-use
• 15.3. Brazil
  • 15.3.1. Pricing Analysis
  • 15.3.2. Market Share Analysis, 2024
    • 15.3.2.1. By Product
    • 15.3.2.2. By Technology
    • 15.3.2.3. By Application
    • 15.3.2.4. By End-use
• 15.4. Mexico
  • 15.4.1. Pricing Analysis
  • 15.4.2. Market Share Analysis, 2024
    • 15.4.2.1. By Product
    • 15.4.2.2. By Technology
    • 15.4.2.3. By Application
    • 15.4.2.4. By End-use
• 15.5. Germany
  • 15.5.1. Pricing Analysis
  • 15.5.2. Market Share Analysis, 2024
    • 15.5.2.1. By Product
    • 15.5.2.2. By Technology
    • 15.5.2.3. By Application
    • 15.5.2.4. By End-use
• 15.6. U.K.
  • 15.6.1. Pricing Analysis
  • 15.6.2. Market Share Analysis, 2024
    • 15.6.2.1. By Product
    • 15.6.2.2. By Technology
    • 15.6.2.3. By Application
    • 15.6.2.4. By End-use
• 15.7. France
  • 15.7.1. Pricing Analysis
  • 15.7.2. Market Share Analysis, 2024
    • 15.7.2.1. By Product
    • 15.7.2.2. By Technology
    • 15.7.2.3. By Application
    • 15.7.2.4. By End-use
• 15.8. Spain
  • 15.8.1. Pricing Analysis
  • 15.8.2. Market Share Analysis, 2024
    • 15.8.2.1. By Product
    • 15.8.2.2. By Technology
    • 15.8.2.3. By Application
    • 15.8.2.4. By End-use
• 15.9. Italy
  • 15.9.1. Pricing Analysis
  • 15.9.2. Market Share Analysis, 2024
    • 15.9.2.1. By Product
    • 15.9.2.2. By Technology
    • 15.9.2.3. By Application
    • 15.9.2.4. By End-use
• 15.10. China
  • 15.10.1. Pricing Analysis
  • 15.10.2. Market Share Analysis, 2024
    • 15.10.2.1. By Product
    • 15.10.2.2. By Technology
    • 15.10.2.3. By Application
    • 15.10.2.4. By End-use
• 15.11. Japan
  • 15.11.1. Pricing Analysis
  • 15.11.2. Market Share Analysis, 2024
    • 15.11.2.1. By Product
    • 15.11.2.2. By Technology
    • 15.11.2.3. By Application
    • 15.11.2.4. By End-use
• 15.12. South Korea
  • 15.12.1. Pricing Analysis
  • 15.12.2. Market Share Analysis, 2024
    • 15.12.2.1. By Product
    • 15.12.2.2. By Technology
    • 15.12.2.3. By Application
    • 15.12.2.4. By End-use
• 15.13. Malaysia
  • 15.13.1. Pricing Analysis
  • 15.13.2. Market Share Analysis, 2024
    • 15.13.2.1. By Product
    • 15.13.2.2. By Technology
    • 15.13.2.3. By Application
    • 15.13.2.4. By End-use
• 15.14. Singapore
  • 15.14.1. Pricing Analysis
  • 15.14.2. Market Share Analysis, 2024
    • 15.14.2.1. By Product
    • 15.14.2.2. By Technology
    • 15.14.2.3. By Application
    • 15.14.2.4. By End-use
• 15.15. Australia
  • 15.15.1. Pricing Analysis
  • 15.15.2. Market Share Analysis, 2024
    • 15.15.2.1. By Product
    • 15.15.2.2. By Technology
    • 15.15.2.3. By Application
    • 15.15.2.4. By End-use
• 15.16. New Zealand
  • 15.16.1. Pricing Analysis
  • 15.16.2. Market Share Analysis, 2024
    • 15.16.2.1. By Product
    • 15.16.2.2. By Technology
    • 15.16.2.3. By Application
    • 15.16.2.4. By End-use
• 15.17. GCC Countries
  • 15.17.1. Pricing Analysis
  • 15.17.2. Market Share Analysis, 2024
    • 15.17.2.1. By Product
    • 15.17.2.2. By Technology
    • 15.17.2.3. By Application
    • 15.17.2.4. By End-use
• 15.18. South Africa
  • 15.18.1. Pricing Analysis
  • 15.18.2. Market Share Analysis, 2024
    • 15.18.2.1. By Product
    • 15.18.2.2. By Technology
    • 15.18.2.3. By Application
    • 15.18.2.4. By End-use
• 15.19. Israel
  • 15.19.1. Pricing Analysis
  • 15.19.2. Market Share Analysis, 2024
    • 15.19.2.1. By Product
    • 15.19.2.2. By Technology
    • 15.19.2.3. By Application
    • 15.19.2.4. By End-use

16. Market Structure Analysis

• 16.1. Competition Dashboard
• 16.2. Competition Benchmarking
• 16.3. Market Share Analysis of Top Players
  • 16.3.1. By Regional
  • 16.3.2. By Product
  • 16.3.3. By Technology
  • 16.3.4. By Application
  • 16.3.5. By End-use

17. Competition Analysis

• 17.1. Competition Deep Dive
  • 17.1.1. Alere, Inc.
    • 17.1.1.1. Overview
    • 17.1.1.2. Product Portfolio
    • 17.1.1.3. Profitability by Market Segments
    • 17.1.1.4. Sales Footprint
    • 17.1.1.5. Strategy Overview
      • 17.1.1.5.1. Marketing Strategy
  • 17.1.2. bioMerieux SA
    • 17.1.2.1. Overview
    • 17.1.2.2. Product Portfolio
    • 17.1.2.3. Profitability by Market Segments
    • 17.1.2.4. Sales Footprint
    • 17.1.2.5. Strategy Overview
      • 17.1.2.5.1. Marketing Strategy
  • 17.1.3. Eiken Chemical Co. Ltd
    • 17.1.3.1. Overview
    • 17.1.3.2. Product Portfolio
    • 17.1.3.3. Profitability by Market Segments
    • 17.1.3.4. Sales Footprint
    • 17.1.3.5. Strategy Overview
      • 17.1.3.5.1. Marketing Strategy
  • 17.1.4. Hologic Inc.(Gen-Probe)
    • 17.1.4.1. Overview
    • 17.1.4.2. Product Portfolio
    • 17.1.4.3. Profitability by Market Segments
    • 17.1.4.4. Sales Footprint
    • 17.1.4.5. Strategy Overview
      • 17.1.4.5.1. Marketing Strategy
  • 17.1.5. Lucigen
    • 17.1.5.1. Overview
    • 17.1.5.2. Product Portfolio
    • 17.1.5.3. Profitability by Market Segments
    • 17.1.5.4. Sales Footprint
    • 17.1.5.5. Strategy Overview
      • 17.1.5.5.1. Marketing Strategy
  • 17.1.6. Meridian Bioscience, Inc.
    • 17.1.6.1. Overview
    • 17.1.6.2. Product Portfolio
    • 17.1.6.3. Profitability by Market Segments
    • 17.1.6.4. Sales Footprint
    • 17.1.6.5. Strategy Overview
      • 17.1.6.5.1. Marketing Strategy
  • 17.1.7. Ustar Biotechnologies Ltd.
    • 17.1.7.1. Overview
    • 17.1.7.2. Product Portfolio
    • 17.1.7.3. Profitability by Market Segments
    • 17.1.7.4. Sales Footprint
    • 17.1.7.5. Strategy Overview
      • 17.1.7.5.1. Marketing Strategy
  • 17.1.8. QIAGEN
    • 17.1.8.1. Overview
    • 17.1.8.2. Product Portfolio
    • 17.1.8.3. Profitability by Market Segments
    • 17.1.8.4. Sales Footprint
    • 17.1.8.5. Strategy Overview
      • 17.1.8.5.1. Marketing Strategy
  • 17.1.9. Quidel Corporation
    • 17.1.9.1. Overview
    • 17.1.9.2. Product Portfolio
    • 17.1.9.3. Profitability by Market Segments
    • 17.1.9.4. Sales Footprint
    • 17.1.9.5. Strategy Overview
      • 17.1.9.5.1. Marketing Strategy
  • 17.1.10. Thermo Fisher Scientific, Inc.
    • 17.1.10.1. Overview
    • 17.1.10.2. Product Portfolio
    • 17.1.10.3. Profitability by Market Segments
    • 17.1.10.4. Sales Footprint
    • 17.1.10.5. Strategy Overview
      • 17.1.10.5.1. Marketing Strategy
  • 17.1.11. BD (Becton, Dickinson & Company)
    • 17.1.11.1. Overview
    • 17.1.11.2. Product Portfolio
    • 17.1.11.3. Profitability by Market Segments
    • 17.1.11.4. Sales Footprint
    • 17.1.11.5. Strategy Overview
      • 17.1.11.5.1. Marketing Strategy

18. Assumptions & Acronyms Used

19. Research Methodology

관련자료